Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway

Oncology Reports

Volumn 26, Issue 6, 2011, Pages 1573-1579

  Li, Shi Sheng ^a   Yang, Shu ^a   Wang, Shuang ^a   Yang, Xin Ming ^a   Tang, Qing Lai ^a   Wang, Shu Hui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Akt; FLIP; Latent membrane protein 1; Nasopharyngeal carcinoma; Resistance; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 8; FLICE INHIBITORY PROTEIN; LATENT MEMBRANE PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BID; PROTEIN KINASE B; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL SURFACE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FLIP GENE; GENE; GENE SILENCING; MITOCHONDRIAL MEMBRANE POTENTIAL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN OVEREXPRESSION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NASOPHARYNGEAL NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; VIRAL MATRIX PROTEINS;

EID: 80053548665     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1423     Document Type: Article

References (30)

1. Walczak H and Krammer PH: The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256: 58-66, 2000.
2. Pan G, Ni J, Wei YF, Yu G, Gentz R and Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815-818, 1997.
3. Green DR and Evan GI: A matter of life and death. Cancer Cell 1: 19-30, 2002.
4. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X: Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998.
5. Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S and Mukhtar H: Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27: 2055-2063, 2008.
6. Szliszka E, Zydowicz G, Janoszka B, Dobosz C, Kowalczyk-Ziomek G and Krol W: Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis. Int J Oncol 38: 4941-4953, 2011.
7. Tang L, Mao Y, Liu L, Liang S, Chen Y, Sun Y, Liao X, Lin A, Liu M, Li L and Ma J: The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer 115: 680-688, 2009.
8. Isobe K, Ito H, Shigematsu N, Kawada T, Yasuda S, Hara R, Machida N, Takano H, Uchida Y, Uno T, Kitahara H and Kubo A: Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: distant metastasis and local recurrence. Int J Oncol 12: 1183-1187, 1998.
9. Shao JY, Wang HY, Huang XM, Feng QS, Huang P, Feng BJ, Huang LX, Yu XJ, Li JT, Hu LF, Ernberg I and Zeng YX: Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol 17: 1267-1275, 2000.
10. Teng MS, Brandwein Gensler MS, Teixeira MS, Martignetti JA and Duffey DC: A study of TRAIL receptors in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 131: 407-412, 2005.
11. Chen LC, Chung IC, Hsueh C, Tsang NM, Chi LM, Liang Y, Chen CC, Wang LJ and Chang YS: The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients. Cell Death Differ 17: 1463-1473, 2010.
12. Ozoren N, Fisher MJ and Kim K: Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance. Int J Oncol 16: 917-925, 2000.
13. Kijima T, Kinukawa N, Gooding WE and Uno M: Association of Epstein-Barr virus with tumor cell proliferation: clinical implication in nasopharyngeal carcinoma. Int J Oncol 18: 479-485, 2001.
14. Tang YL, Lu JH, Cao L, Wu MH, Peng SP, Zhou HD, Huang C, Yang YX, Zhou YH, Chen Q, Li XL, Zhou M and Li GY: Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes. Braz J Med Biol Res 41: 110-116, 2008.
15. Du CX, Wen BG, Li DR, Peng X, Hong CQ, Chen JY, Lin ZZ, Hong X, Lin YC, Xie LX, Wu MY and Zhang H: Arsenic trioxide reduces the invasive and metastatic properties of nasopharyngeal carcinoma cells in vitro. Braz J Med Biol Res 39: 677-685, 2006.
16. Mei YP, Zhou JM, Wang Y, Huang H, Deng R, Feng GK, Zeng YX and Zhu XF: Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 6: 1379-1385, 2007.
17. Dawson CW, Tramountanis G, Eliopoulos AG and Young LS: Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem 278: 3694-7304, 2003.
18. Oka N, Tanimoto S, Taue R, Nakatsuji H, Kishimoto T, Izaki H, Fukumori T, Takahashi M, Nishitani M and Kanayama H: Role of phosphatidylinositol-3 kinase/Akt pathwayin bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci 10: 1093-1098, 2006.
19. Dieterle A, Orth R, Daubrawa M, Grotemeier A, Alers S, Ullrich S, Lammers R, Wesselborg S and Stork B: The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. Int J Cancer 125: 932-941, 2009.
20. Sarkar MC, Bae SI, Reu FJ, Jacobs BS, Lindner DJ and Borden EC: Down-regulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ 11: 915-923, 2004.
21. Kaufmann SH and Earnshaw WC: Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256: 42-49, 2000.
22. Hitt MM, Allday MJ and Hara T: EBV gene expression in an NPC-related tumor. EMBO J 8: 2639-2651, 1989.
23. Wang D, Liebowitz D and Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43: 831-840, 1985.
24. Lin SY, Tsang NM and Kao SC: Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma. Head Neck 23: 194-200, 2001.
25. + B lymphoma cell lines from patients with post-transplant lymphoproliferative disease are resistant to TRAIL-induced apoptosis. Am J Transplant 6: 976-985, 2006.
26. Tschopp J, Irmler M and Thome M: Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10: 552-558, 1998.
27. Wang J, Lobito AA, Shen F, Hornung F, Winoto A and Lenardo MJ: Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol 30: 155-163, 2000.
28. Chang DW, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart BC, Yaish-Ohad S, Peter ME and Yang X: c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J 21: 3704-3714, 2002.
29. Liu HY, Wen GB, Han JM, Hong T, Zhuo DG, Liu ZQ and Cao WH: Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway. J Biol Chem 283: 30642-30649, 2008.
30. Oka N, Tanimoto S, Taue R, Nakatsuji H, Kishimoto T, Izaki H, Fukumori T, Takahashi M, Nishitani M and Kanayama HO: Role of phosphatidylinositol-3 kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci 97: 1093-1098, 2006.